Previous Article | Next Article 
Journal of Virology, December 1999, p. 9952-9958, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Similar Interactions of the Poliovirus and
Rhinovirus 3D Polymerases with the 3' Untranslated Region of
Rhinovirus 14
Janet M.
Meredith,1
Jonathan B.
Rohll,2
Jeffrey W.
Almond,1,
and
David
J.
Evans3,*
School of Animal and Microbial Sciences, The
University of Reading, Reading RG6 5AJ,1
Oxford BioMedica (UK) Limited, Oxford OX4
4GA,2 and Division of Virology,
Institute of Biomedical and Life Sciences, University of Glasgow,
Glasgow G11 5JR,3 United Kingdom
Received 15 March 1999/Accepted 31 August 1999
 |
ABSTRACT |
We showed previously that a human rhinovirus 14 (HRV14) 3'
untranslated region (3' UTR) on a poliovirus genome was able to replicate with nearly wild-type kinetics (J. B. Rohll, D. H. Moon, D. J. Evans, and J. W. Almond, J. Virol
69:7835-7844, 1995). This enabled the HRV14 single 3' UTR stem-loop
structure to be studied in combination with a sensitive reporter
system, poliovirus FLC/REP, in which the capsid coding region is
replaced by an in-frame chloramphemicol acetyltransferase (CAT) gene.
Using such a construct, we identified a mutant (designated mut4), in
which the structure and stability of the stem were predicted to be
maintained, that replicated very poorly as determined by its level of
CAT activity. The effect of this mutant 3' UTR on replication has been
further investigated by transferring it onto the full-length cDNAs of
both poliovirus type 3 (PV3) and HRV14. Virus was recovered with a
parental plaque phenotype at a low frequency, indicating the
acquisition of compensating changes, which sequence analysis revealed
were, in both poliovirus- and rhinovirus-derived viruses, located in
the active-site cleft of 3D polymerase and involved the substitution of
Asn18 for Tyr. These results provide further evidence of a specific
interaction between the 3' UTR of picornaviruses and the viral
polymerase and also indicate similar interactions of the 3' UTR of
rhinovirus with both poliovirus and rhinovirus polymerases.
 |
INTRODUCTION |
The picornaviruses are small,
nonenveloped RNA viruses, classified into six genera, of which the
enteroviruses (including poliovirus and coxsackievirus) and the human
rhinoviruses are members. These two genera, the most closely related of
the Picornaviridae, are similar with respect to genomic
organization, polyprotein structure, and processing pattern, and they
produce viral proteins that function in essentially the same manner
(24, 27). The single-stranded positive-sense RNA genome
contains all of the signals required for translation of the viral
polyprotein and replication of the genome within the cell cytoplasm.
The polyprotein is cleaved posttranslationally into three regions; P1
produces the capsid proteins (VP1 to VP4), while P2 (2A to 2C) and P3
(3A to 3D) are the precursors of proteins involved in polyprotein maturation and RNA replication. The poliovirus RNA-dependent RNA polymerase, the 3D gene product, is responsible for the synthesis of
negative strands from the input RNA, which are then copied to produce
new positive-sense RNA. However, all of the P2 and P3 proteins,
including several cleavage intermediates, have been implicated in some
aspect of replication (for a review see reference 33).
The most 5' proximal of the RNA structures, the poliovirus cloverleaf
(CL; nucleotides [nt] 1 to 88), is the site of ribonucleoprotein complex formation required in the positive sense for replication (2). Complex formation involves the viral protease 3CD
binding to the CL, either in conjunction with 3AB or following the
binding of a cellular protein of 36 kDa which has been identified as
the poly(rC) binding protein PCBP2 (1, 7, 17). The remainder of the unusually long 5' untranslated region (UTR) forms an internal ribosome entry site involved in translation (28).
Whereas similar 5' CLs are present in all entero- and rhinoviruses, the
structures of the 3' UTRs are diverse with regard to length and
structure (20). Despite this variation, the 3' structures
formed fall into three main groups, the primary and secondary
structures within each group being very highly conserved (23). Experimental evidence suggests that the 3' UTR plays a key role in replication, as demonstrated by the inability to replace it
with nonviral structures (26) or by the recovery of mutants that prevent tertiary interactions within this region and require reversions or compensating mutations to restore viability (13, 15,
21). However, this role in replication is difficult to correlate
with the observed ability to interchange picornavirus 3' UTRs with
grossly different structures; e.g., the 3' UTRs of coxackievirus B4 and
human rhinovirus 14 (HRV14), with three and one stem-loops,
respectively, can functionally replace the 3' UTR of poliovirus type 3 (PV3), which has two stem-loops (26).
Evidence from cross-linking and electrophoretic mobility shift assays
have shown that, in common with CL, the 3' UTRs may be involved in
ribonucleoprotein complex formation. The poliovirus proteins 3AB and
3CD have been shown to bind to this region, as have cellular proteins
which are distinct from those which bind CL (7, 14, 29, 34).
More recently, both polio- and rhinoviruses with partial or complete
deletions of their 3' UTRs have been recovered, indicating that these
structures may not be absolute requirements for virus replication
(31).
In a previous study, we showed that a chimeric poliovirus genome
bearing an HRV14 3' UTR replicated with nearly wild-type (wt) kinetics
(26). This enabled the single stem-loop structure of HRV14,
the most basic 3' UTR, to be studied in the context of a subgenomic
replicon (designated FLC/REP 19) that expresses a chloramphenicol
acetyltransferase (CAT) reporter gene. A highly conserved base-paired
motif at the base of the rhinovirus 3' stem (23) was
mutagenized, and one mutant (mut4), predicted to have a stem structure
with a stability similar to that of the unmodified structure, showed
levels of CAT expression only marginally above that of a replicon
bearing a deletion within 3D polymerase, reflecting a significant
defect in replication (26).
In this work, we have studied the effects of this replication-defective
mutant on virus viability and replication efficiency. The HRV14 mut4 3'
UTR was transferred to full-length PV3 and HRV14 cDNAs, and virus was
recovered from both constructs. We have investigated the effect that
this mutation has on the infectivity of in vitro-transcribed RNA, the
requirement for compensating mutations elsewhere in the genome, and the
phenotype of recovered viruses. We suggest that although not absolutely
required for replication, the function of the 3' UTR involves an
interaction with the active-site cleft of the viral polymerase.
 |
MATERIALS AND METHODS |
Construction of replicons and full-length cDNA clones.
pT7/FLC, an infectious clone of PV3 (19), has already been
reported, as have derivatives in which the 3' UTR was replaced by HRV14
sequences (26). The HRV14 mut4 3' UTR was transferred from
the corresponding poliovirus replicon (26) to pT7/FLC on a
1.2-kb XbaI-SalI fragment [nt 6265 to 3' of the
poly(A) tract] to generate pT7/FLC.mut4.
A T7 promoter was engineered preceding an infectious cDNA clone of
HRV14 (27) in the vector pJM1, a pAT153 derivative in which
the tetracycline gene was replaced with a kanamycin resistance cassette
(14a), to generate pT7/HRV14. pT7/HRV14.mut4 was constructed in several stages due to the presence of duplicated restriction sites.
The HRV14 3' UTR was amplified from pT7/FLC.mut4 (primers 01-0280 and
06-0051; all primers are listed in Table
1), and the unique
PstI-SalI fragment was cloned into pSL301
(Invitrogen). The adjacent HRV14-derived
XbaI-HpaI fragment (nt 6525 to 7167) was
introduced into the latter plasmid digested with SpeI and HpaI (pSL301 to nt 7167), and the mut4 3' UTR was excised
and rebuilt into pT7/HRV14, using a unique SphI site (nt
6632) and an AatII site present in both vectors after the
poly(A) tail.
The construction of a 3' UTR deletion of HRV14 was made in an
AseI-ClaI (nt 6568 to vector) subclone in a
similarly cut preparation of pAT153. Oligonucleotide 285 (Table 1) was
self-annealed, and the ends were filled in with Klenow prior to
ScaI digestion. The resulting product was built into
HpaI-ScaI (nt 7167 to vector)-digested and
phosphatase-treated pAT153-derived subclone, and the modified 3' region
was returned to pT7/HRV14 on unique SphI-ClaI (nt
6632 to vector) sites to generate pT7/HRV14.
3'.
Reverse transcription-PCR-amplified fragments from recovered viruses
were rebuilt into cDNA (pT7/FLC.mut4 or pT7/HRV14.mut4)
to map the
locations of compensating mutations. Viral RNA (vRNA)
was extracted
from plaque-purified viruses as described previously
(
25)
and reverse transcribed by using primer 06-0051. Primer
pairs
34-0042-06-0051 and 50-0005-43-0006 were used to amplify
poliovirus
nt 5993 to 3' of the poly(A) tract and nt 4115 to 6553,
respectively,
which were rebuilt into pT7/FLC.mut4 on
XbaI/
SalI
[nt 6265 to 3' of the poly(A) tract] or
HindIII [nt
4241 to 6507]
fragments, to create pT7/FLC.X/S and pT7/FLC.mut4.H. The
HindIII
fragment was further dissected by using the
NarI site at nt 5815,
enabling the
NarI-
XhoI (nt 5815 to 6050) and
XmaI-
NarI (nt 2766
to 5815) fragments to be
cloned independently and reciprocally
from the parental and
FLC.mut4-derived clones into pSL310. The
resulting individual mutations
were rebuilt into pT7/FLC.mut4
on the unique
XmaI-
XhoI fragment (nt 2766 to 6050) to yield
plasmids
pT7/FLC.mut4.3C and pT7/FLC.mut4.3D, respectively. The 3D
mutation
was subsequently transferred into pT7/FLC.3'HRV14 to yield
plasmid
pT7/FLC.3'HRV14.3D.
The 3CD region of HRV14 was amplified by using primers 01-300 and
01-0301 and cloned on an
EcoRV fragment (nt 5490 to 6048)
into the pT7/HRV14.mut4 cDNA, to generate pT7HRV14.mut4.E.
In vitro transcriptions and transfections.
Poliovirus- and
rhinovirus-derived cDNAs were linearized with SalI and
ClaI, respectively, prior to T7-mediated in vitro
transcription as described previously (32). Samples of the
transcription reactions were fractionated by agarose gel
electrophoresis to assess yields, and similar quantities were serially
diluted 10-fold prior to transfection (5), with the
modification that the transfection buffer was Hanks balanced salt
solution (10× stock contains 50 g of HEPES, 80 g of NaCl,
3.7 g of KCl, and 1.25 g of
Na2HPO4 · 2H2O/liter, pH
7.05), plus final concentrations of 1 g of glucose and 0.5 g
of dextran/liter.
Sequencing of recovered virus.
All DNA sequencing was
performed on a Pharmacia ALF Express, using suitable Cy5-labelled
primers. Direct RNA sequencing was carried out as described previously
(5). Poliovirus- or rhinovirus-derived RNA was reverse
transcribed with primer 06-0051 prior to PCR amplification of the
required region. Primers 06-0051 and 34-0086 were used to amplify the
3' UTR of FLC.mut4, which was sequenced with primer 01-0292. Primers
01-0289, 01-0290, 01-0291, and 3Dseq were used to sequence the
amplified and cloned HindIII fragment (nt 4241 to 6507),
and the identified mutations were confirmed by RNA sequencing with
primer 01-0291.
Primer pairs 01-0294 and 01-0295 were used to amplify the 3' UTR of
HRV14.mut4, and the sequence determined with primer 01-0293.
The RNA
encoding the amino terminus of HRV14 3D was sequenced
by using primer
01-0299, and the HRV14-derived
EcoRV fragment
containing the
mutation (nt 5495 to 6052) was amplified with primers
01-0300 and
01-0301, sequenced with 01-0302, and rebuilt by using
standard
protocols.
Growth characteristics.
The growth of plaque-purified,
recovered viruses was assessed in a one-step growth curve as described
previously (26). Virus yields were quantified by plaque
assay for the poliovirus- and HRV14-based mutant viruses and by 50%
tissue culture infective dose for the HRV14 3'-deleted viruses
(5).
 |
RESULTS |
Recovery of poliovirus with an HRV14 mut4 3' UTR.
We have used
a poliovirus subgenomic replicon (designated FLC/REP), in which a CAT
reporter gene is fused in frame with VP2 of PV3 (19), to
determine the effect of 3' UTR substitutions and mutations on genome
replication (26). Replacement of the poliovirus 3' UTR of
FLC/REP with the HRV14 3' UTR (to generate FLC/REP.3'HRV14) produced a
chimeric replicon that exhibited almost wt levels of replication
(26), despite the complete lack of homology between these 3'
UTRs (Fig. 1A and B). A derivative of FLC/REP.3'HRV14, designated FLC/REP.mut4, bearing a modification of the
conserved base of the stem (Fig. 1B) exhibited only background levels
of CAT activity, despite having a structure and predicted stability
close to that of the native HRV14 3' UTR. To assess its effect on virus
viability, the mut4 3' UTR was transferred from the replicon to a
full-length PV3 cDNA (pT7FLC) to generate pT7FLC.mut4.
Subconfluent Ohio HeLa cells were transfected with RNA
transcribed in vitro, and plaques were observed at a frequency ~3
log10 below that for the control pT7FLC.3'HRV14 RNA
(compare Fig. 2A and B). This reduction
in specific infectivity (routinely measured in parallel experiments at
~106 PFU/µg for pT7FLC-derived viruses) suggests that
viability requires the acquisition of a mutation by reversion either at
a key sequence within the mut4 3' UTR or elsewhere in the genome.
Although the majority of plaques obtained were very small, some
exhibited a phenotype similar to that of FLC.3'HRV14 (visible in the
100 dilution in Fig. 2B).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Structures and sequences of 3' UTRs. (A) Secondary
structure of the PV3 3' UTR. (B) Structure of the HRV14 3' UTR showing
the sequence change at the base of the stem to generate mut4. (C)
Conserved sequence at the base of the 3' stem of human rhinoviruses.
(D) The 3' UTR sequence remaining after removal of the stem-loop to
generate HRV14. 3'.
|
|

View larger version (145K):
[in this window]
[in a new window]
|
FIG. 2.
In vitro-transcribed RNA from poliovirus-based cDNAs
serially diluted (100 to 10 5), transfected
into Ohio HeLa cells, and overlaid with semisolid agar. pT7FLC.3'HRV14
(A) has a wt HRV14 3'UTR, and pT7FLC.mut4 (B) has a stem mutant 3' UTR.
Other constructs, based on pT7FLC.mut4, include reverse-transcribed and
PCR-amplified fragments from recovered virus. pT7FLC.mut4.X/S (C) and
pFLC.mut4.H (D) contain the XbaI/SalI and
HindIII fragments, respectively. pT7FLC.mut4.3C (E) and
pT7FLC.mut4.3D (F) contain the identified 3C and 3D mutations
respectively.
|
|
Identification of compensating mutations within the poliovirus
genome.
To determine whether the large-plaque variant of FLC.mut4
retained the original mut4 3' UTR mutation, two independent plaques were picked and subjected to two rounds of plaque purification, and a
180-nt fragment spanning the entire 3' UTR was PCR amplified and
sequenced. The sequences obtained from both plaques were identical to
that of the pT7FLC.mut4 cDNA, indicating that the compensating mutation(s) must be located elsewhere in the genome.
The P3 region of the genome was thought to be the most likely location
for compensating mutations. It has been reported that
the 3' UTR of
poliovirus binds P3-encoded proteins in cross-linking
assays
(
7), and there are results to support the formation
of a
pseudoknot between the 3' UTR of enteroviruses and the coding
region
(
9), although no evidence for a similar tertiary structure
was found for HRV14 (
30). vRNA from one of the purified
viruses
was isolated, and two overlapping fragments covering the P3
region
were amplified by PCR. Both the
XbaI-
SalI
[nt 6265 to 3' of the
poly(A) tract] and
HindIII (nt
4241 to 6507) fragments were independently
rebuilt into pFLC.mut4 to
generate pT7FLC.mut4.X/S and pT7FLC.mut4.H,
respectively (Fig.
3A). Whereas the infectivity of the RNA
transcribed
in vitro from pT7FLC.mut4.X/S was identical to the original
pT7FLC.mut4,
that bearing the
HindIII fragment,
pT7FLC.mut4.H, was indistinguishable
by infectivity and plaque
morphology from pT7FLC.3'HRV14 (Fig.
2A, C, and D). Any compensating
mutations required to restore
wt levels of replication must therefore
be located within this
2.2-kb
HindIII fragment. Direct
sequencing of the entire 2.2-kb
HindIII fragment in
pT7FLC.mut4H resulted in the identification
of only two nucleotide
substitutions: a noncoding change of thymidine
5779 to cytidine
(T
5779C) within the region encoding 3C, and
A
6029T,
which introduces a coding change of asparagine to
tyrosine at
amino acid 18 of 3D (Fig.
4A). Although 3D, as part of 3CD, binds
to the poliovirus 3' UTR, the reported pseudoknot between the
3' UTR
and coding region (
9) and recent reports of
cis-acting
replication signals within picornavirus genomes
(
5a,
11,
12)
meant that the T
5779C noncoding
change in 3C could not be discounted
from contributing to the phenotype
of the revertant virus. The
two changes were introduced independently
into pT7FLC.mut4 to
generate plasmids pT7FLC.mut4.3C and
pT7FLC.mut4.3D, respectively.
In vitro-transcribed RNA bearing the 3C
noncoding change alone
recovered as the original pT7FLC.mut4, whereas
pT7FLC.mut4.3D
was indistinguishable from FLC.mut4H and FLC.3'HRV14
(Fig.
2E
and F). Direct RNA sequencing confirmed that both original
purified
plaques harbored the 3D mutation of A
6029T but
that only one had
the 3C mutation. Therefore, the single coding change
in poliovirus
3D polymerase is sufficient to compensate for the HRV14
3' UTR
mut4 stem mutation present in FLC.mut4.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Construction of PV3- and HRV14-based clones. Shaded
areas are reverse-transcribed and PCR-amplified fragments from
recovered mut4 virus. (A) All constructs are based on PV3 (Leon) with
an HRV14 mut4 3' UTR (FLC.mut4); the restriction endonuclease sites
used are indicated, and the constructs generated are shown. (B) HRV14
cDNAs were constructed by using the restriction sites shown.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Alignment of amino acids 8 to 36 of the PV3 and
HRV14 polymerases. The observed nucleotide and amino acid changes are
shown for both. (B to D) Tenfold serial dilutions (100 to
10 5) of RNA generated in vitro from pT7HRV14 (B),
pT7HRV14.mut4 (C), and pT7HRV14.mut4.E (D) with substitution of the
EcoRV fragment from recovered virus, transfected into Ohio
HeLa cells, and overlaid directly with agar.
|
|
Recovery of the mut4 3' UTR on the homologous human
rhinovirus.
Alignment of PV3 and HRV14 3D sequences indicates that
residue 18, which is conserved as an asparagine in the enteroviruses, hepatoviruses, and HRV14, marks the amino terminus of a region of
significant homology between the two proteins (Fig. 4A) and so may
represent a functionally conserved domain. We were interested to
determine the phenotype of rhinovirus bearing the mut4 mutation in the
3' UTR and, if it was less fit than the parental virus, to identify any
compensating mutations that are required to restore wt growth
characteristics. The mut4 3' UTR was engineered in place of the native
sequence in a full-length HRV14 cDNA to generate pT7HRV14.mut4.
Transfection of in vitro-produced pT7HRV14.mut4 RNA generated small,
indistinct plaques after 4 days (Fig.
4C), and infectivity
was reduced
~10-fold compared to RNA generated from pT7HRV14 (compare
Fig.
4B and
C). Therefore, although pT7HRV14.mut4 RNA was infectious,
virus
replication was significantly impaired compared to that
of wt HRV14.
Our pT7HRV14 cDNA is routinely used to generate RNA
with a specific
infectivity of ~10
4 PFU/µg, but we were unable to
identify revertants with a large-plaque
phenotype by direct
transfection. Therefore, recovery of the in
vitro-transcribed RNA on
cells with a liquid overlay was attempted.
Virus in the supernatant,
transferred to fresh cells with an agar
overlay, generated a mixture of
large and small plaques (data
not shown), suggesting that one or more
compensating mutations
are required for efficient replication of HRV14
with the mut4
3'
UTR.
Identification of a compensating mutation within the HRV14
genome.
A recovered virus with a large-plaque phenotype was
subjected to two rounds of plaque purification, the vRNA was isolated, and a 380-nt fragment spanning the 3' UTR was amplified by PCR, sequenced directly, and confirmed to be identical to the cDNA from
which the virus was recovered. A further fragment of 1.5 kb spanning
the amino terminus of 3D was amplified and sequenced; it contained a
single substitution of A to T at nucleotide 5833, within the codon for
residue 18 of HRV14 3D. To confirm that this mutation confers the wt
phenotype and to exclude the possibility that the recovered virus
contained additional compensating mutations, a fragment was amplified
from the reverse-transcribed material to include the EcoRV
sites at nt 5490 and 6048. This 558-nt fragment was reintroduced into
the original pT7HRV14.mut4 cDNA (Fig. 3). In vitro-transcribed RNA was
transfected into Ohio HeLa cells and shown to be as infectious as
T7-generated HRV14 RNA and to produce plaques of comparable phenotype
(Fig. 4D). The DNA sequence of the 558-bp EcoRV fragment in
pHRV14.mut4.E was determined and found to contain only the single
substitution of A5833T.
The effect of 3D Tyr18 on FLC.3'HRV14 replication.
3D
polymerase N18Y has been identified as the only mutation
required to compensate for the mut4 mutation on either a poliovirus or
HRV14 genome. We were interested to investigate the effect of 3D
tyrosine 18 on the phenotype of poliovirus in the absence of the
modified mut4 3' UTR. Recovery of virus from this construct (pT7FLC.3'HRV14.3D) showed that the specific infectivity of in vitro-transcribed RNA was similar to that of pT7FLC.3'HRV14 but fractionally larger plaques were produced (data not shown). To characterize this virus further, we compared it to FLC.3'HRV14 and
FLC.mut4.3D in a single-step growth curve. It grew to a titer about 0.5 log10 higher than titers of the other two viruses (Fig. 5). Therefore, the 3D polymerase mutation
that is absolutely required to compensate for the defective HRV14 mut4
3' UTR on a chimeric poliovirus is capable of replicating the
FLC.3'HRV14.3D genome at or above the rate of FLC.3'HRV14.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Plaque-purified PV3-HRV14 chimeric viruses were used to
infect Ohio HeLa cells at a multiplicity of infection of 10 for a
one-step growth curve to compare N18Y viruses. Mut4 has the
3' stem mutant, and the 3D N18Y mutation is present where
indicated. , FLC.3'HRV14; , FLC.3'HRV14.3D; , FLC.mut4.3D.
|
|
If N
18Y acted by nonspecifically increasing the activity of
the polymerase, we would expect it to be equally effective in
compensating for other debilitating mutations of the 3' UTR. We
have
generated a 3' UTR deletion of HRV14 essentially similar
to that
recently published by Todd et al. (
31) which retains
only
six nucleotides between the polyprotein termination codon
and the
poly(A) tract (Fig.
1D). Transfection of in vitro-transcribed
RNA from
pT7/HRV14.

3' generated a viable virus only following
passage of the
transfection supernatant onto a fresh cell monolayer.
Further serial
passage to optimize the replication potential was
undertaken, and the
growth kinetics at passage 5 and 13 were analyzed
by single-step growth
curve. In agreement with the results of
Todd et al., viruses purified
by limit dilution grew to a final
titer ~1 log
10 less
than that of the parental HRV14 (Fig.
6).
The extended period required to observe replicating virus following
transfection is indicative of the accumulation of several compensating
mutations. Full analysis of these viruses will be published elsewhere;
however, sequencing of the 3' UTR and the region encoding the
amino
terminus of 3D confirmed that there were no modifications
to the UTR
and that residue 18 of 3D remained an asparagine.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
One-step growth curve to compare wt HRV14 with
HRV14. 3' recovered virus following 5 or 13 passages in tissue
culture. , HRV14. 3', passage 13; , HRV14. 3', passage 5;
, HRV14. TCID50, 50% tissue culture infective dose.
|
|
 |
DISCUSSION |
The poliovirus, rhinovirus, and coxsackievirus 3' UTRs are
distinctly different in sequence and structure but remain functionally interchangeable, in both chimeric poliovirus subgenomic replicons and
infectious cDNAs (26). The high level of 3' UTR sequence conservation within each of these three groups and variation between them suggests a conserved and specific role for this region of the
genome. However, although it is clear that nonviral synthetic stem-loop
structures cannot replace the 3' UTR without destroying viability
(26), the recent demonstration that the 3' UTRs of poliovirus and rhinovirus can be removed entirely (this study and
reference 31) complicates the understanding of the
function of this region.
We have extended our analysis of the 3' UTR by studying a chimeric
poliovirus bearing a mutagenized rhinovirus 3' UTR. The mutation,
described in an earlier report (26), was designed to disrupt
a highly conserved base paired motif at the base of the single
stem-loop within the HRV14 3' UTR (Fig. 1B and c). As a subgenomic
replicon, this resulted in background levels of replication. However,
when the mutation was engineered onto a full-length poliovirus cDNA and
transfected, plaques with wild-type phenotype arose at a frequency
consistent with the acquisition of a single compensating mutation (Fig.
2). Characterization of two independent virus isolates demonstrated the
presence of an A-to-U substitution at nt 6029. The importance of the
A6029U substitution in compensating for the mut4
modification of the HRV14 3' UTR was confirmed by rebuilding this
mutation alone into the parental pT7/FLC.mut4 and demonstrating the
acquisition of a plaque phenotype indistinguishable from that of
pT7/FLC.3'HRV14 (Fig. 2). The A6031U substitution
introduces a tyrosine in place of asparagine at position 18 of the 3D
polymerase. It is interesting to note that 3D polymerase residue 18 is
an asparagine in the enteroviruses, hepatitis A virus, and HRV14, which
include all of the 3' UTRs that we have previously demonstrated confer
viability to a poliovirus replicon, but is a histidine in all other
picornaviruses (including other rhinoviruses). Whether this residue
plays a key role in the replication of these chimeric replicons or
simply reflects the evolutionary relationships between the
picornaviruses remains to be determined. Although not characterized
further, we would speculate that the relatively abundant small plaque
phenotype viruses also observed during the recovery of the poliovirus
N18Y mutants represent the acquisition of partially
compensating transitional mutations; these are known to occur far more
frequently than transversions in poliovirus (3, 10) but
presumably could not fully restore efficient replication to the virus.
To confirm that the N18Y substitution in poliovirus 3D
polymerase is not selected as a consequence of the chimeric nature of
the FLC.mut4 genome, we investigated the phenotype of HRV14 bearing an
identical mut4 3' UTR. The recovery of an identical N18Y
substitution within the rhinovirus 3D polymerase, arising from a single
A5833U mutation, emphasizes both the similarity of the two
viruses and the importance of the amino acid substitution in 3D
polymerase in restoring virus replication. This finding also strongly
suggests that it is the amino acid substitution, rather than the
underlying alteration in nucleotide sequence, that is responsible for
the change in phenotype. Alignment of the nucleotide sequences encoding
the first 25 amino acids of the poliovirus and rhinovirus 3D polymerase
shows only 36% identity, with no evidence for any conserved
higher-order structures. This conclusion is in agreement with the
structural analysis of the 3' UTR of rhinovirus by Todd and Semler
(30), who could find no evidence for interactions of the
coding and noncoding regions.
Assuming that it is the N18Y substitution that is critical
for replication competence, the mechanism by which this is achieved remains to be determined. One possibility is that substitution directly
effects the interaction of polymerase and substrate and that this
specific mutation is required to accommodate the 3' UTR bearing the
mut4 modification. The location of residue 18 in the poliovirus 3D
polymerase structure certainly does not preclude this possibility.
Although the N terminus of 3D polymerase was largely disordered in the
crystal structure, the location of residues 12 to 37 can be visualized
as forming the N-terminal strand of the thumb subdomain (6)
occupying one side of the active-site cleft. Although the R factor is
insufficient to be confident about side chain orientation, Asn18 is
located toward the base of the cleft, exposed to the palm domain, which
contains the four consensus motifs conserved in all classes of
polymerase (16). However, although Asn18 is clearly located
within the active-site cleft, it is not clear how it might contribute
to polymerization activity.
The limited number of mutations generated in the N terminus of
poliovirus 3D polymerase (for a review, see reference
16) throw little light on the function of this
region of the protein. Deletion of residues 1 to 6, or of Trp5 alone
(6, 22), inactivates the enzyme, and charged-to-alanine
substitutions at Lys36 and Glu29, which are located at the top of the
thumb domain in a region of ordered structure, prevent the recovery of
viable virus (4). One intriguing possibility, suggested by
the crystal structure, is that the N terminus of 3D polymerase is
involved in oligomerization. Residues 12 to 37 are situated on the
opposite side of the polymerase from the next ordered segment, residues
67 to 97. It is unlikely that the intervening disordered residues (38 to 66) span almost 45 Å directly across the active site of the
polymerase, and it is therefore probable that residues 12 to 37 visible
in a polymerase monomer are actually derived from an adjacent molecule
(6). Polymerase-polymerase interactions have been
demonstrated by independent techniques (8, 18), and in vitro
analysis suggests cooperativity in RNA binding and polymerization
activity (18). This experimental evidence is supported by
analysis of the packing of the polymerase molecules in crystals, which
suggests that two significant interfaces are present (6).
One of these (interface II, using the nomenclature of Hansen et al.
[6]) involves a trans interaction of two
polymerase proteins, in which residues 12 to 37 and 67 to 97 make
contact. This suggests that the N18Y substitution may
mediate its effect, either directly by a contribution to RNA
interactions within the active site cleft or indirectly by affecting
the interaction and oligomerization of polymerase monomers into
higher-order structures.
One possibility, addressed in this study, is that the N18Y
mutation acts by increasing polymerase activity and so compensates for
a rate-limiting step introduced by modification of the 3' UTR. This
interpretation is supported by the growth characteristics of
FLC/3'HRV14.3D (Fig. 5). In our previous study, we demonstrated that
FLC/3'HRV14 accumulates to a final titer approximately 0.5 log10 lower than that of unmodified poliovirus FLC
(26). The introduction of the mut4 mutation and acquisition
of the N18Y substitution (to yield FLC.mut4.3D) restores
replication to levels comparable to those for FLC.3'HRV14 (Fig. 5). In
contrast, introduction of the N18Y substitution to
FLC.3'HRV14 (generating FLC/3'HRV14.3D) produces a virus that
replicates slightly better than either FLC.3'HRV14 or FLC.mut4.3D, at
levels comparable to those for FLC (Fig. 5). However, if this were the
case, one would expect there to be a selective pressure to acquire an
N18Y substitution in other instances of debilitating
modifications to the 3' UTR. A severe test of this hypothesis would be
the recovery of a virus in which the entire 3' UTR was deleted. The
recovery and preliminary analysis of HRV14.
3' suggest that the
N18Y mutation is not required to restore viability to this
virus. This, in turn, may suggest that the N18Y mutation is
specifically required to compensate for a defective 3' UTR, rather than
the total absence of such a sequence, possibly strengthening the case
that this region of the polymerase is involved in direct RNA interactions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Virology, University of Glasgow, Church St., Glasgow, G11 5JR, United Kingdom. Phone and fax: 44 (0)141 330 6249. E-mail:
David.Evans{at}vir.gla.ac.uk.
Present address: Pasteur Mérieux Connaught, 69280 Marcy-L'Etoile, France.
 |
REFERENCES |
| 1.
|
Andino, R.,
G. E. Rieckhof,
P. L. Achacoso, and D. Baltimore.
1993.
Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA.
EMBO J.
12:3587-3598[Medline].
|
| 2.
|
Andino, R.,
G. E. Rieckhof, and D. Baltimore.
1990.
A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA.
Cell
63:369-380[Medline].
|
| 3.
|
Delatorre, J. C.,
C. Giachetti,
B. L. Semler, and J. J. Holland.
1992.
High-frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus.
Proc. Natl. Acad. Sci. USA
89:2531-2535[Abstract/Free Full Text].
|
| 4.
|
Diamond, S. E., and K. Kirkegaard.
1994.
Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis.
J. Virol.
68:863-876[Abstract/Free Full Text].
|
| 5.
|
Evans, D. J., and J. W. Almond.
1991.
Design, construction and characterization of poliovirus antigen chimeras.
Methods Enzymol.
203:387-400.
|
| 5a.
| Goodfellow, I. G. Y. Chaudhry, A. Richardson, J. M. Meredith, J. W. Almond, W. S. Barclay, and D. J. Evans.
Identification of a cis-acting replication element (CRE)
within the poliovirus coding region. Submitted for publication.
|
| 6.
|
Hansen, J. L.,
A. M. Long, and S. C. Schultz.
1997.
Structure of the RNA-dependent RNA polymerase of poliovirus.
Structure
5:1109-1122[Abstract/Free Full Text].
|
| 7.
|
Harris, K. S.,
W. Xiang,
L. Alexander,
W. S. Lane,
A. V. Paul, and E. Wimmer.
1994.
Interaction of poliovirus polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding.
J. Biol. Chem.
269:27004-27014[Abstract/Free Full Text].
|
| 8.
|
Hope, D. A.,
S. E. Diamond, and K. Kirkegaard.
1997.
Genetic dissection of interaction between poliovirus 3D polymerase and viral protein 3AB.
J. Virol.
71:9490-9498[Abstract].
|
| 9.
|
Jacobson, S. J.,
D. A. M. Konings, and P. Sarnow.
1993.
Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification.
J. Virol.
67:2961-2971[Abstract/Free Full Text].
|
| 10.
|
Kuge, S., and A. Nomoto.
1987.
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.
J. Virol.
61:1478-1487[Abstract/Free Full Text].
|
| 11.
|
McKnight, K. L., and S. M. Lemon.
1996.
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA.
J. Virol.
70:1941-1952[Abstract].
|
| 12.
|
McKnight, K. L., and S. M. Lemon.
1998.
The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.
RNA
4:1569-1584[Abstract].
|
| 13.
|
Melchers, W. J. G.,
J. G. J. Hoenderop,
H. J. B. Slot,
C. W. A. Pleij,
E. V. Pilipenko,
V. I. Agol, and J. M. D. Galama.
1997.
Kissing of the two predominant hairpin loops in the coxsackie B virus 3' untranslated region is the essential structural feature of the origin of replication required for negative-strand RNA synthesis.
J. Virol.
71:686-696[Abstract].
|
| 14.
|
Mellits, K. H.,
J. M. Meredith,
J. B. Rohll,
D. J. Evans, and J. W. Almond.
1998.
Binding of a cellular factor to the 3' untranslated region of the RNA genomes of entero- and rhinoviruses plays a role in virus replication.
J. Gen. Virol.
79:1715-1723[Abstract].
|
| 14a.
| Meredith, J. M., and D. J. Evans.
Unpublished data.
|
| 15.
|
Mirmomeni, M. H.,
P. J. Hughes, and G. Stanway.
1997.
An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication.
J. Virol.
71:2363-2370[Abstract].
|
| 16.
|
O'Reilly, E. K., and C. C. Kao.
1998.
Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure.
Virology
252:287-303[Medline].
|
| 17.
|
Parsley, T. B.,
J. S. Towner,
L. B. Blyn,
E. Ehrenfeld, and B. L. Semler.
1997.
Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase.
RNA
3:1124-1134[Abstract].
|
| 18.
|
Pata, J. D.,
S. C. Schultz, and K. Kirkegaard.
1995.
Functional oligomerization of poliovirus RNA-dependent RNA polymerase.
RNA
1:466-477[Abstract].
|
| 19.
|
Percy, N.,
W. S. Barclay,
M. Sullivan, and J. W. Almond.
1992.
A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.
J. Virol.
66:5040-5046[Abstract/Free Full Text].
|
| 20.
|
Pilipenko, E. V.,
S. V. Maslova,
A. N. Sinyakov, and V. I. Agol.
1992.
Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs a proposal for the existence of tert-RNA-like terminal structures.
Nucleic Acids Res.
20:1739-1745[Abstract/Free Full Text].
|
| 21.
|
Pilipenko, E. V.,
K. V. Poperechny,
S. V. Maslova,
W. J. G. Melchers,
H. J. Bruins Slot, and V. I. Agol.
1996.
Cis-element, oriR, involved in the initiation of ( ) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary ("kissing") interactions.
EMBO J.
15:5428-5436[Medline].
|
| 22.
|
Plotch, S. J.,
O. Palant, and Y. Gluzman.
1989.
Purification and properties of poliovirus RNA polymerase expressed in Escherichia coli.
J. Virol.
63:216-225[Abstract/Free Full Text].
|
| 23.
|
Poyry, T.,
L. Kinnunen,
T. Hyypia,
B. Brown,
C. Horsnell,
T. Hovi, and G. Stanway.
1996.
Genetic and phylogenetic clustering of enteroviruses.
J. Gen. Virol.
77:1699-1717[Abstract/Free Full Text].
|
| 24.
|
Racaniello, V. R., and D. Baltimore.
1981.
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome.
Proc. Natl. Acad. Sci. USA
78:4887-4891[Abstract/Free Full Text].
|
| 25.
|
Rico Hesse, R.,
M. A. Pallansch,
B. K. Nottay, and O. M. Kew.
1987.
Geographic distribution of wild poliovirus type 1 genotypes.
Virology
160:311-322[Medline].
|
| 26.
|
Rohll, J. B.,
D. H. Moon,
D. J. Evans, and J. W. Almond.
1995.
The 3' untranslated region of picornavirus RNA: features required for efficient genome replication.
J. Virol.
69:7835-7844[Abstract].
|
| 27.
|
Stanway, G.,
P. J. Hughes,
R. C. Mountford,
P. D. Minor, and J. W. Almond.
1984.
The complete nucleotide sequence of a common cold virus: human rhinovirus 14.
Nucleic Acids Res.
12:7859-7875[Abstract/Free Full Text].
|
| 28.
|
Stewart, S. R., and B. L. Semler.
1997.
RNA determinants of picornavirus cap-independent translation initiation.
Semin. Virol.
8:242-255.
|
| 29.
|
Todd, S.,
J. H. C. Nguyen, and B. L. Semler.
1995.
RNA-protein interactions directed by the 3' end of human rhinovirus genomic RNA.
J. Virol.
69:3605-3614[Abstract].
|
| 30.
|
Todd, S., and B. L. Semler.
1996.
Structure-infectivity analysis of the human rhinovirus genomic RNA 3'-noncoding region.
Nucleic Acids Res.
24:2133-2142[Abstract/Free Full Text].
|
| 31.
|
Todd, S.,
J. S. Towner,
D. M. Brown, and B. L. Semler.
1997.
Replication-competent picornaviruses with complete genomic RNA 3' noncoding region deletions.
J. Virol.
71:8868-8874[Abstract].
|
| 32.
|
Van der Werf, S.,
J. Bradley,
E. Wimmer,
F. W. Studier, and J. J. Dunn.
1986.
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:2330-2334[Abstract/Free Full Text].
|
| 33.
|
Wimmer, E.,
C. U. T. Hellen, and X. M. Cao.
1993.
Genetics of poliovirus.
Annu. Rev. Genet.
27:353-436[Medline].
|
| 34.
|
Xiang, W.,
A. V. Paul, and E. Wimmer.
1997.
RNA signals in entero- and rhinovirus genome replication.
Semin. Virol.
8:256-273.
|
Journal of Virology, December 1999, p. 9952-9958, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Headey, S. J., Huang, H., Claridge, J. K., Soares, G. A., Dutta, K., Schwalbe, M., Yang, D., Pascal, S. M.
(2007). NMR structure of stem-loop D from human rhinovirus-14. RNA
13: 351-360
[Abstract]
[Full Text]
-
Karakasiliotis, I., Chaudhry, Y., Roberts, L. O., Goodfellow, I. G.
(2006). Feline calicivirus replication: requirement for polypyrimidine tract-binding protein is temperature-dependent.. J. Gen. Virol.
87: 3339-3347
[Abstract]
[Full Text]
-
van Ooij, M. J. M., Polacek, C., Glaudemans, D. H. R. F., Kuijpers, J., van Kuppeveld, F. J. M., Andino, R., Agol, V. I., Melchers, W. J. G.
(2006). Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element. Nucleic Acids Res
34: 2953-2965
[Abstract]
[Full Text]
-
Brown, D. M., Cornell, C. T., Tran, G. P., Nguyen, J. H. C., Semler, B. L.
(2005). An Authentic 3' Noncoding Region Is Necessary for Efficient Poliovirus Replication. J. Virol.
79: 11962-11973
[Abstract]
[Full Text]
-
Yang, Y., Rijnbrand, R., Watowich, S., Lemon, S. M.
(2004). Genetic Evidence for an Interaction between a Picornaviral cis-Acting RNA Replication Element and 3CD Protein. J. Biol. Chem.
279: 12659-12667
[Abstract]
[Full Text]
-
Goodfellow, I. G., Polacek, C., Andino, R., Evans, D. J.
(2003). The poliovirus 2C cis-acting replication element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes. J. Gen. Virol.
84: 2359-2363
[Abstract]
[Full Text]
-
GOODFELLOW, I. G., KERRIGAN, D., EVANS, D. J.
(2003). Structure and function analysis of the poliovirus cis-acting replication element (CRE). RNA
9: 124-137
[Abstract]
[Full Text]
-
Witwer, C., Rauscher, S., Hofacker, I. L., Stadler, P. F.
(2001). Conserved RNA secondary structures in Picornaviridae genomes. Nucleic Acids Res
29: 5079-5089
[Abstract]
[Full Text]
-
Polacek, C., Lindberg, A. M.
(2001). Genetic characterization of the coxsackievirus B2 3' untranslated region. J. Gen. Virol.
82: 1339-1348
[Abstract]
[Full Text]
-
Goodfellow, I., Chaudhry, Y., Richardson, A., Meredith, J., Almond, J. W., Barclay, W., Evans, D. J.
(2000). Identification of a cis-Acting Replication Element within the Poliovirus Coding Region. J. Virol.
74: 4590-4600
[Abstract]
[Full Text]